Why migraine hits women more often—and what helps

A CBS News report examines why migraine is more common in women, how hormone shifts may play a role, and which evidence-based steps can help reduce attacks.
Estrogen Patch Shortages Are Disrupting Menopause Care

A shortage of estradiol patches is making it harder for some patients to fill menopause prescriptions. Here is what the FDA says, what evidence supports the treatment, and what remains unclear.
How Midlife Hormone Shifts Can Affect Heart, Bone, Brain and Metabolism

Menopause is a normal transition, but it can coincide with changes in cardiovascular risk, bone density, sleep, cognition and vaginal comfort. Here’s what the evidence shows and what is still being studied.
What New Evidence Says About Hormone Therapy and Heart Risk

Newer research is reshaping how clinicians talk about menopause hormone therapy and cardiovascular risk, but experts say it is still a symptom treatment, not a heart-disease prevention plan.
What the science says about hormone therapy and dementia risk

A recent debate over menopause hormone therapy has renewed a familiar question: does treatment affect dementia risk? Here’s what current evidence can and cannot tell us.
How heart risk shifts for women across life stages

New guidance highlights that cardiovascular risk in women is not static. Blood pressure, pregnancy complications, menopause, and other transitions can all change the picture.
New menopause guidance broadens the treatment playbook

Updated guidance on menopause symptoms emphasizes individualized care, with hormone therapy still central for many people and nonhormonal options for those who cannot or prefer not to use it.
State ballot measures put abortion access and reproductive care in focus

Voters in several states are deciding abortion-related ballot measures that could reshape access to reproductive health care, while other proposals may affect how state elections are run.
A gentler path to checking for endometrial cancer may be emerging

A clinician-collected vaginal swab is being studied as an easier first step for evaluating symptoms that can signal endometrial cancer. The approach is promising, but it is not yet a replacement for standard diagnosis.
Testosterone Therapy and Heart Safety: What Women Should Know

New research presented at a menopause conference raises fresh questions about cardiovascular safety in women using testosterone therapy, which is not FDA-approved for women.